Drugs / CE Ferulic
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT06603857 Comparator | Sep → Dec 2024 overdue | — | Goldman, Butterwick, Fitzpatrick and Groff | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CE Ferulic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06603857 ↗ |